COVID-19 vaccine

In the next phase of the race to vaccinate Americans, the Biden administration knows the government is not the best messenger. So it's asking communities for help.

While emphasizing that the risk is low, the health agency said there should be a warning about the rare condition included in the product information for the vaccine.

The CDC reported a hopeful statistic in the country's fight against the coronavirus on Sunday. On Monday, every adult in the country will be eligible to register to be vaccinated.

The largest number of deaths have come in the United States, Brazil, Mexico, India and the United Kingdom. The pandemic death toll reached 1 million in September 2020 and 2 million in January.

No vaccine is 100% effective. Though so-called "breakthrough" COVID cases are rare, the virus is circulating widely. What's a vaccinated person to do? And ... not do?

An expert advisory committee to the CDC decided it needed more time to consider whether to recommend the restart administration of the COVID-19 vaccine made by Johnson & Johnson.

Government health officials are recommending a "pause" in vaccinations with the Johnson & Johnson COVID-19 vaccine. We're answering your questions as we learn more.

COVID-19 vaccines are highly effective but don't always provide perfect protection. Some vaccinated people later exposed to the virus still get sick. Why and how often that happens is under study.

Just 12 days after Bhutan launched a nationwide vaccination campaign on March 27, health officials said 93% of eligible adults had received one dose of AstraZeneca's COVID-19 vaccine.

More campuses are expected to add the requirement, with potential legal challenges ahead. One key point: Requiring vaccines for infectious diseases is nothing new for many residential colleges.

The European Medicines Agency said Wednesday that blood clots should be listed as a possible but rare side effect of the AstraZeneca COVID-19 vaccine, stressing the shot's benefits outweigh the risks.

The president said states must open vaccine eligibility to all U.S. residents 18 and older by April 19, about two weeks ahead of his initial May 1 deadline.